Virtual Practice
Recommend
Add to your Care-Team

Dr. Kathleen Mullane

Internal Medicine
Chicago, IL
About
Insights
Network
Welcome!
About me
I specialize in
Internal Medicine
Internal Medicine - Infectious Disease
I have been in practice
30 years
I speak
English
I'm known for
Doctor
Votes
Member
Votes
Recommend me
My answers and insights have
Saved 2 lives
Helped 658,800 people
Received 668 doctor agrees
Received 521 thanks
Here are kind words from others
Dr. Mullane's excellent answers are well thought out and completely reliable.
good answers and excellent doctor
Highly recommended!!
Recommend me
I am located at
University of Chicago
5841 S. Maryland Avenue MC: 5065
Chicago , IL 60546
I was educated and trained at
Medical / Graduate School
Midwestern University Chicago College of Osteopathic Medicine, IL
1989
Philadelphia University of the Sciences
University of Iowa
1980
Fellowships
Infectious Diseases University of Chicago/University of Illinois combined Infectious Diseases Fellowship Program
Academic Appointments
Associate Professor of Medicine
I'm affiliated with
Organizations
University of chicago medical center
Advocate lutheran general hospital
Illinois masonic medical center
Macneal hospital
Hospitals
University Of Chicago
I've won the following awards
Top Infectious Disease Specialist , Illinois
Winter 2013
Top General Internist, Illinois
Summer 2013
US News and World Report Top Doctor (Castle Connelly) 2012
I've published
Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy.
BMC infectious diseases, 13, 148 (2013)
M A Miller, T Louie, K Mullane, K Weiss, A Lentnek, Y Golan, Y Kean, P Sears
Activity of Daptomycin with or without 25 Percent Ethanol Compared to Combinations of Minocycline, EDTA, and 25 Percent Ethanol against Methicillin-Resistant Staphylococcus aureus Isolates Embedded in Biofilm.
Antimicrobial agents and chemotherapy, 57, 1998-2000 (2013)
R Estes, J Theusch, A Beck, D Pitrak, K M Mullane
Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 55 Suppl 2, S121-6 (2012)
M M Nerandzic, K Mullane, M A Miller, F Babakhani, C J Donskey
Here are some of my top insights